Nevertheless, almost all investigators agree that neither lack of family history nor late disease onset are reliable indicators of BRCA1 wild-type status in OC patients, therefore DNA testing of non-selected ovarian cancer cases is recommended by some laboratories. Here, BRCA1 is linked to ovarian carcinoma.